Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Change in Account Payables (2023 - 2026)

Compass Therapeutics' Change in Account Payables history spans 4 years, with the latest figure at -$679000.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 1.04% to -$679000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$671000.0, a 192.81% decrease, with the full-year FY2025 number at -$664000.0, up 63.93% from a year prior.
  • Change in Account Payables hit -$679000.0 in Q1 2026 for Compass Therapeutics, up from -$1.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CMPX hit a ceiling of $1.8 million in Q4 2023 and a floor of -$3.2 million in Q1 2024.
  • Historically, Change in Account Payables has averaged -$190461.5 across 4 years, with a median of -$232000.0 in 2024.
  • The widest YoY moves for Change in Account Payables: up 315.52% in 2025, down 217.15% in 2025.
  • Tracing CMPX's Change in Account Payables over 4 years: stood at $1.8 million in 2023, then dropped by 27.75% to $1.3 million in 2024, then plummeted by 217.15% to -$1.5 million in 2025, then soared by 55.03% to -$679000.0 in 2026.
  • Business Quant data shows Change in Account Payables for CMPX at -$679000.0 in Q1 2026, -$1.5 million in Q4 2025, and $500000.0 in Q3 2025.